Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Superyacht Industry Leaders Support Development of New ABS Rules

Advances in Safety, Sustainability and Flexible Design Discussed(COPENHAGEN) ABS brought together leading global yacht designers, shipyards and Flag Administrations to help develop new ABS rules to advance safety in superyacht and megayacht design and operation. Attendees at the inaugural ABS European Yacht Technical Meeting discussed the technology and innovation required by the yachts of the future, with a focus on flexible design compatible with emerging technologies. “Developing sustainable yachts that meet clients’ demand for greener yachts over long operational lives presents

BioStock: Emplicure’s co-founder on the company’s next step

Since it was founded in 2014, Emplicure has transformed from being a company with potential and ambitions of going public to today having one drug candidate heading into clinical studies and a consumer product ready to premiere in June. A person who has been involved throughout the company’s journey is co-founder Thomas Lundqvist, who resigned as chairman of the board in April. BioStock spoke to Lundqvist about his new role and how he sees the company’s future.Read the full article at biostock.se : https://www.biostock.se/en/2022/05/emplicures-medgrundare-om-

Magnolia Bostad announces final tender results and issues new senior unsecured green bonds of SEK 300 million

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

Musti Group plc – Managers' transactions – Dettel

Musti Group plc – Managers' transactions – Dettel Musti Group plc            Managers’ transactions                  12 May 2022, at 3.30 p.m. Musti Group Oyj - Managers’ transactions                  ____________________________________________ Person subject to the notification requirement Name: Johan Dettel Position: Member of the Board/Deputy member Issuer: Musti Group LEI: 743700IE9NQGF9YZAI97 Notification type: INITIAL NOTIFICATION Reference number: 14841/4/4 ____________________________________________ Transaction date: 2022-05-11 Venue: NASDAQ

Invitation to presentation of Q1 2022 results

DOF ASA will release the Q1 results on Thursday 19th of May 2022. The report will be available at www.dof.com and www.newsweb.no. The presentation will be held as a webcast at 08:30 CET the same day on: http://www.dof.com/webcast. The presentation will be held by CEO Mons S. Aase and CFO Hilde Drønen.If you have questions, please contact the Company. Contact:CEO Mons Aase,     Tel + 47 91 66 10 12CFO Hilde Drønen, Tel + 47 91 66 10 09

Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in HusCompagniet's shares

Company announcement 29/2022 Pursuant to the Market Abuse Regulation article 19, HusCompagniet A/S, CVR no. 36972963 ("HusCompagniet" or the “Company”), shall hereby notify receipt of information of the following transactions made by persons discharging managerial responsibilities in HusCompagniet and persons closely associated with them in HusCompagniet's shares and other financial instruments linked thereto. 1 Details of the Reporting Person and their Closely Associated Personsa) Name Stig Pastwa2 Reason for the notificationa)

BioStock: Sprint Bioscience maintains focus on developing the portfolio

With the activities for 2022 in full swing, Sprint Bioscience publishes the report for the year’s first quarter where we can note a continued focus on developing the programs in the portfolio. The company will begin presenting the latest internal program in the portfolio to potential partners and a scientific council has been appointed to support the future development. BioStock contacted the company’s CEO Erik Kinnman to get his thoughts on the first quarter.Read the full article at biostock.se:https://www.biostock.se/en/2022/05/sprint-bioscience-maintains-focus-on-developing-the-

Communiqué from Annual General Meeting in BoMill AB

Idag, den 12 maj 2022, hölls årsstämma i BoMill AB (publ), 556556-4332. Nedan följer en sammanfattning av de beslut som fattades. Samtliga beslut fattades med erforderlig majoritet. Today, May 12, 2022, the Annual General Meeting of BoMill AB (publ), 556556-4332, was held. Below is a summary of the decisions made. All decisions were made by the required majority.Beslut om dispositioner beträffande bolagets resultat enligt den fastställda balansräkningen (punkt 8b) och ansvarsfrihet (punkt 8c) / Resolution regarding the allocation of the company’s results in accordance with the adopted

Getinge reaches record deliveries of vascular grafts to customers

After ramping up the production of polyester grafts and patches to treat aneurysmal and occlusive diseases, Getinge is now reaching delivery records, supporting health care staff around the world in the treatment of hundreds of patients per day with the help of these solutions. The demand for Getinge’s high quality vascular grafts is growing and following a 3 Million Euro investment in 2020 to increase manufacturing capacity at the Getinge La Ciotat (France) factory, the medtech supplier is reaching record months of deliveries to their customers. “Together with partners and

New technology from SaltX enables production of "green quick lime" – results verified by the industry

SaltX Technology´s innovation is called Electric Arc Calciner (EAC), which can electrify the production of quick lime and at the same time separate and capture CO2 from the limestone. The innovation has the potential to remove all emissions from the lime industry. Leading actors in the sector have verified the positive results. Lime is one of the most common materials in the world. It is an essential material for manufacturing steel, building materials, paper, and is also used in purification of water among many other use cases. Together with the cement industry, they account for 19

BLIXT solid state circuit breakers for self-monitoring of data centers

BLIXT, the company behind BLIXT Zero, the world’s first IEC certified miniature solid state circuit breaker, today announces a collaboration project with RISE ICE, Europe’s leading research data center. The project objective is to pilot BLIXT Zero for predictive maintenance in data centers and quantify cost and energy savings through optimized operations.Data centers across the globe host over 100 million servers and the $288 Bn market continues to grow rapidly.  Any interruptions in a data center’s operation can have enormous chain effects and the risks associated with any fault is high,

OKEA ASA - Minutes of annual general meeting

(Trondheim, 12 May 2022) OKEA ASA (OSE: OKEA) On 12 May 2022 at 09.00 OKEA ASA held an annual general meeting as a digital meeting with online participation. Item 12 of the notice of annual general meeting as published 21 April 2022 contained a proposal from a shareholder regarding additional compensation to the members of the board. In the meeting, the shareholder modified its proposal during the annual general meeting. The modification was of technical nature and the final proposal and corresponding resolution are stated in the minutes. All other proposals on the agenda were adopted.

Gram Car Carriers ASA: Minutes from annual general meeting

The annual general meeting of Gram Car Carriers ASA ("GCC") was held today, 12 May 2022. The minutes from the meeting are attached to this notice and will be made available on the company's website, https://gramcar.com/investor/annual-general-meetings. All items on the agenda were approved, including the distribution of a cash dividend in the amount of approx. NOK 0.3482 per share (equivalent to approx. USD 0.0362), in total NOK 9,999,600 (equivalent to USD 1,040,000). The dividend is expected to be paid on or about 9 June 2022 to the shareholders of GCC as of 12 May 2022, as registered

Everfuel presents first quarter 2022 results on Thursday, 19 May

Herning, 12 May 2022 – Everfuel A/S will release its financial results for the first quarter 2022 on Thursday, 19 May at 07:00 CEST. CEO Jacob Krogsgaard and CFO Anders Bertelsen will present the company's results at 09:00 CEST and invite investors, analysts, and media to join the live webcast presentation. The presentation is expected to last up to one hour, including the Q&A session.  Webcast: Join the results webcast via the following link: Everfuel first quarter 2022 presentation 

Volumental Makes Key C-Suite Hire and Forms New Team to Fuel Global Expansion

Retail industry’s premier FitTech solution appoints Patrik Brakenhielm as CFO, leveraging Series A fundraise to grow commercial team and expand presence in China   STOCKHOLM, May 12, 2021 – Volumental , a computer vision company that helps the world's top retailers and brands solve fit, improve customer experiences, and transform data into fuel for profitable growth, today announced a number of growth initiatives to support the company’s global expansion. Following its Series A fundraise in December, Volumental has bolstered its C-suite with a Chief

CLS Americas Debuts Office-Based, Fusion-Guided TRANBERG Focal Laser Ablation System at AUA 2022 Conference

CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced it will debut its Office-Based, MR/US Fusion-Guided, TRANBERG® Thermal Therapy System  for high precision, focal laser ablation of soft tissue, such as prostate cancer tumors, at the upcoming AUA 2022 Conference being held May 13-16, 2022 in New Orleans.  The system is designed to work with multiple MR/US fusion image guidance systems for precise and accurate ablation in a minimally invasive setting, while preserving healthy prostate tissue. Focal

iLOQ Sustainability Report published

During 2021, we crystallized our sustainability strategy and clarified our strategy in various areas of ESG. Sustainability is a key part of our business and related to our strategic goals. Sustainability is essentially related to everything we do. iLOQ takes a holistic 360-degree approach to sustainability. This means looking at all ESG factors not only in the company's day-to-day operations, but across the entire supply chain and throughout the lifecycle of its solutions. Continuous development of the circular economy and sustainable performance is an important part of iLOQ'

Picosun solution enables stretchable organic electronics manufacturing on large scale

ESPOO, Finland, 12th of May 2022 - Organic electronics enable everyday devices such as displays, lighting and sensors to have high energy efficiency, light weight and low manufacturing costs. These benefits have made organic electronics a mainstream technology today and great steps have been taken to realize the technology’s true potential.  Finally, flexible and stretchable circuitry can be fabricated, paving the way for wearable devices and e-textiles. This technological leap has left behind traditional encapsulation methods, such as heavy glass lids with limited stretchability. The

Communiqué from Genovis AB (publ) Annual General Meeting May 12, 2022

The Annual General Meeting adopted the following resolutions:· The Balance Sheet and Income Statement as well as the Consolidated Income Statement and the Consolidated Balance Sheet were adopted. · The Board and the Chief Executive Officer were discharged from liability. · The Board shall consist until the next AGM of five ordinary members without deputies. · Re-election of Board members Torben Jørgensen, Mikael Lönn, Lotta Ljungqvist and Steve Jordan. Magnus Gustafsson was elected new Board member. Torben Jørgensen was elected Chairperson of the Board. ·

SameSystem secures new capital by commitment from Vækstfonden and major shareholder

Company Announcement No. 9-2022Copenhagen, 12 May 2022Inside Information SameSystem A/S (“SameSystem”) receives conditional commitment from the Danish Growth Fund (“Vækstfonden”) to provide a matching loan for up to 12,000,000 DKK to be paid out in two tranches of 5,000,000 DKK and 7,000,000 DKK. The interest rate CIBOR 3 + 7.19 % pro annum and is payable quarterly. The tranches are repayable six (6) years after payment of the tranches. The payouts under the loan facility is conditional upon certain conditions and prerequisites are fulfilled. Further, SameSystem has the opportunity

Announcement from 24SevenOffice's annual general meeting

The annual general meeting 2022 ("AGM") of 24SevenOffice Group AB ("24SevenOffice" or the "Company") was held on 11 May 2022 and the following resolutions were passed by the meeting.Adoption of the income statement and the balance sheet The AGM resolved to adopt the income statement and the balance sheet in 24SevenOffice and the consolidated income statement and the consolidated balance sheet. Allocation of profit The AGM resolved not to pay any dividend to the shareholders and that the previously accrued profits, including the share premium account and year result would be carried

First day of trading in Sensidose AB

Today is the first day of trading in Sensidose AB, a Swedish pharmaceutical company which develops and sells individualised dosing of medicines for the medical treatment of Parkinson’s disease.Sensidose has developed the drug Flexilev® which, in combination with the proprietary MyFID® dosing device, individualises and adjust the treatment of Parkinson's disease. The Company's vision is to improve the quality of life for patients with chronic diseases through improved individualised medication, leading to better efficacy and reduced side effects of given treatment. The Company is now in a

There are no items matching the current filter
There are no more items matching the current filter
Back to top